Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Crit Rev Oncol Hematol. 2016 Dec 1;109:69–78. doi: 10.1016/j.critrevonc.2016.11.017

Figure 3.

Figure 3

main miR-34a targets. MiR-34a downregulates many genes by binding their three prime untranslated region (red). MiR-34a is also known as an activator of the major p53 pathway (green).